Patents by Inventor Louis William Licamele

Louis William Licamele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT
    Publication number: 20190211107
    Abstract: The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Application
    Filed: March 18, 2019
    Publication date: July 11, 2019
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20190133991
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 9, 2019
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Cancer treatment
    Patent number: 10265282
    Abstract: The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: April 23, 2019
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20190070144
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: November 5, 2018
    Publication date: March 7, 2019
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 10149829
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: December 11, 2018
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • CANCER TREATMENT
    Publication number: 20180256522
    Abstract: The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Application
    Filed: May 15, 2018
    Publication date: September 13, 2018
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • MULTIPLE MYELOMA TREATMENT
    Publication number: 20180256521
    Abstract: The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • METHOD OF TREATMENT WITH TRADIPITANT
    Publication number: 20180110761
    Abstract: This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment pruritus with tradipitant.
    Type: Application
    Filed: March 4, 2016
    Publication date: April 26, 2018
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20180071245
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: November 26, 2017
    Publication date: March 15, 2018
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 9855241
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: January 2, 2018
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20170304256
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: July 7, 2017
    Publication date: October 26, 2017
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 9730910
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: August 15, 2017
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • METHOD OF TREATMENT
    Publication number: 20170165222
    Abstract: Embodiments of the invention relate generally to increasing adult height in individuals with no light perception (NLP).
    Type: Application
    Filed: December 15, 2016
    Publication date: June 15, 2017
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20170100366
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: December 16, 2016
    Publication date: April 13, 2017
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20170087123
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: December 14, 2016
    Publication date: March 30, 2017
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 9549913
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: January 24, 2017
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 9539234
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: January 10, 2017
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CYR61- AND VEGF-MEDIATED CONDITIONS
    Publication number: 20160213696
    Abstract: The invention relates generally to the treatment of CYR61- and VEGF-mediated conditions and, more particularly to the treatment of such conditions by administering to an individual a CYR61 downregulator. In one embodiment, the invention provides a method of treating a CYR61-mediated condition in an individual in need of such treatment, the method comprising: administering to the individual an effective amount of at least one CYR61 downregulator (CYR61DR), wherein the effective amount is an amount sufficient to decrease expression of the CYR61 gene in the individual.
    Type: Application
    Filed: September 4, 2014
    Publication date: July 28, 2016
    Inventors: Mihael H. POLYMEROPOULOS, Louis William LICAMELE, Christian LAVEDAN
  • MULTIPLE MYELOMA TREATMENT
    Publication number: 20160199324
    Abstract: The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Application
    Filed: August 22, 2014
    Publication date: July 14, 2016
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • Treatment of circadian rhythm disorders
    Patent number: RE46604
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: November 14, 2017
    Assignee: VANDA PHARMACEUTICALS, INC.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos